UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 20, 2026
Accession Number:
0001493152-26-039052
Submission Type:
POS AM
CIK:
0002029039
Company Name:
Nasus Pharma Ltd
File Number:
333-293950